Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis
Clin Infect Dis
.
2013 Dec;57(12):1786-7.
doi: 10.1093/cid/cit565.
Epub 2013 Sep 17.
Authors
Malgorzata Mikulska
1
,
Anna Maria Raiola
,
Alessio Signori
,
Elisa Furfaro
,
Valerio Del Bono
,
Andrea Bacigalupo
,
Claudio Viscoli
Affiliation
1
Division of Infectious Diseases, San Martino University Hospital and Department of Health Sciences, University of Genoa.
PMID:
24046295
DOI:
10.1093/cid/cit565
No abstract available
Publication types
Letter
Comment
MeSH terms
Female
Hematopoietic Stem Cell Transplantation / mortality*
Humans
Invasive Pulmonary Aspergillosis / mortality*
Male
Mannans / blood*
Substances
Mannans